Acasti Pharma Inc ACST
$3.28 $0.10 (3.14%) 1D
Last Updated: Nov 22, 12:00 AM·XFRA
Pricing for DE stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is Acasti Pharma Inc Stock Halal?
Shariah Compliance Analysis of ACST Stock
Germany Health Care Nano Cap No. As of September 2026, Acasti Pharma Inc (ACST) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Acasti Pharma Inc does not pass Musaffa's business and financial screening criteria.
Acasti Pharma, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. The company is headquartered in Laval, Quebec. The company went IPO on 2013-03-07. The firm is targeting three underserved orphan diseases: GTX-104, an intravenous infusion targeting subarachnoid hemorrhage (SAH), a rare and life-threatening medical emergency, in which bleeding occurs over the surface of the brain in the subarachnoid space between the brain and skull; GTX-102, an oral mucosal spray targeting ataxia-telangiectasia (A-T), a progressive, neurodegenerative genetic disease that primarily impacts children causing severe disability; and GTX-101, a topical spray, targeting postherpetic neuralgia, a persistent and often debilitating neuropathic pain caused by nerve damage from the varicella zoster virus (shingles). The Company’s clinical assets have each been granted Orphan Drug Designation by the FDA, which provides seven years of marketing exclusivity post-launch in the United States, and additional intellectual property protection.
ACST Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Acasti Pharma Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Acasti Pharma Inc (ACST) Chart
Financial Metrics & Statements of Acasti Pharma Inc (ACST)
FAQ's for Acasti Pharma Inc (ACST)
- As of September 2026, Acasti Pharma Inc ACST is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Acasti Pharma Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Acasti Pharma Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Acasti Pharma Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Acasti Pharma Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Acasti Pharma Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Acasti Pharma Inc (ACST)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
